2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid | 147403-32-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
• 英文别名: 2-Cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid；2-cyclopropyl-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
• CAS: 147403-32-5
• 化学式: C₂₆H₂₀N₄O₄
• 分子量: 452.469
• InChiKey: NNELFNDZSUNNHS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  34
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid 在 4-二甲氨基吡啶 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 24.0h， 生成 (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
  参考文献：
  名称：

  WO2006/107062

  摘要：

  公开号：
• 作为产物：
  描述：

  阿齐沙坦杂质(P) 在 盐酸 、 sodium hydroxide 、 盐酸羟胺 、 碳酸氢钠 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 三乙胺 作用下， 以 四氢呋喃 、 乙醇 、 水 、 二甲基亚砜 、 乙酸乙酯 为溶剂， 反应 29.33h， 生成 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
  参考文献：
  名称：

  WO2006/107062

  摘要：

  公开号：

文献信息

• Compound which is angiotensin II antagonist
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05243054A1

  公开（公告）日：1993-09-07

  ##STR1## compounds shown by the above formula or salt thereof show a strong angiotensin II antagonistic activity and hypotensive action and CNS activity, and are useful as therapeutic agents of circulatory diseases such as hypertensive diseases and heart diseases (e.g. hypercardia, heart failure, cardiac infarction), strokes, cerebral apoplexy, nephritis, atherosclerosis, Alzheimer's disease, senile dementia, etc.

  上述公式所示的##STR1##化合物或其盐表现出强烈的抗肾素II活性和降压作用以及中枢神经系统活性，并且可用作循环系统疾病（如高血压病和心脏病（例如高心排血量、心力衰竭、心肌梗死）、中风、脑卒中、肾炎、动脉粥样硬化、阿尔茨海默病、老年痴呆症等）的治疗剂。
• Benzimidazole Derivative and Use as Angiotensin II Antagonist
  申请人：Kuroita Takanobu

  公开号：US20090054502A1

  公开（公告）日：2009-02-26

  The present invention provides (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate represented by the formula: which has superior properties as a pharmaceutical agent, a salt thereof, a crystal thereof, a pharmaceutical agent containing the compound, and the like.

  本发明提供了(5-甲基-2-氧代-1,3-二氧杂环-4-基)甲基2-环丙基-1-[2'-(5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)联苯-4-基]甲基}-1H-苯并咪唑-7-羧酸酯，其具有作为药物剂的优越性能、其盐、晶体、含有该化合物的药物剂等。
• BENZIMIDAZOLE DERIVATIVE AND USE AS ANGIOTENSIN II ANTAGONIST
  申请人：Kuroita Takanobu

  公开号：US20120172401A1

  公开（公告）日：2012-07-05

  The present invention provides (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate represented by the formula: which has superior properties as a pharmaceutical agent, a salt thereof, a crystal thereof, a pharmaceutical agent containing the compound, and the like.

  本发明提供了一种(5-甲基-2-氧代-1,3-二氧杂环[4,5-]戊基)甲基-2-环丙基-1-[2′-(5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)联苯-4-基]甲基}-1H-苯并咪唑-7-羧酸酯，其具有优越的药物作用，其盐、晶体、含有该化合物的药物制剂等。
• Use of an angiotensin II antagonist as an ocular hypotensive agent
  申请人：TAKEDA CHEMICAL INDUSTRIES, LTD.

  公开号：EP0631780A1

  公开（公告）日：1995-01-04

  This invention relates to an ocular hypotensive agent which comprises a compound represented by the formula: wherein R¹ represents hydrogen or an optionally substituted hydrocarbon residue that may be bound via a hetero atom; R² represents hydrogen or a hydrocarbon residue that may have a substituent; R³ represents a group capable of forming an anion or a group capable of changing thereto; X is a covalent bond between the 2 benzene rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n represents 1 or 2; ring A is a benzene ring having 1 or 2 optional substituents in addition to the group represented by COOR², or a pharmaceutically acceptable salt thereof.

  本发明涉及一种降眼压剂，它由一种由式表示的化合物组成： 其中R¹代表氢或可通过杂原子结合的任选取代的烃残基；R²代表氢或可具有取代基的烃残基；R³代表能够形成阴离子的基团或能够转变为阴离子的基团；X是2个苯环之间的共价键或链长为1至2个原子的间隔物，作为相邻亚苯基和苯基之间的线性分子；n代表1或2；环A是除COOR²代表的基团外具有1或2个任选取代基的苯环，或其药学上可接受的盐。
• PHARMACEUTICAL PACKAGE
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1990052A1

  公开（公告）日：2008-11-12

  The present invention relates to a pharmaceutical package including a pharmaceutical preparation containing 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl or 2-cyclopropyl-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl or a salt thereof, and a desiccant. According to the present invention, a pharmaceutical package having a decreased uncomfortable odor is provided.

  本发明涉及一种药物包，包括一种药物制剂，其中含有 2-乙氧基-1-[2'-(5-氧代-4,5-二氢-1,2,4-恶二唑-3-基)联苯-4-基]甲基}-1H-苯并咪唑-7-羧酸（5-甲基-2-氧代-1、2-环丙基-1-[2'-(5-氧代-4,5-二氢-1,2,4-恶二唑-3-基)联苯-4-基]甲基}-1H-苯并咪唑-7-羧酸(5-甲基-2-氧代-1,3-二氧戊环-4-基)甲基或其盐，以及干燥剂。根据本发明，提供了一种具有较低不适气味的药品包装。